XTCY.F Stock Overview
Xtacy Therapeutics Corp. formerly known as Global Wellness Strategies Inc.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Xtacy Therapeutics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.029 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.0068 |
| Beta | -0.72 |
| 11 Month Change | -62.11% |
| 3 Month Change | n/a |
| 1 Year Change | -64.00% |
| 33 Year Change | -75.59% |
| 5 Year Change | -82.00% |
| Change since IPO | -99.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| XTCY.F | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.9% |
| 1Y | -64.0% | 41.7% | 32.3% |
Return vs Industry: XTCY.F underperformed the US Capital Markets industry which returned 41.7% over the past year.
Return vs Market: XTCY.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| XTCY.F volatility | |
|---|---|
| XTCY.F Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: XTCY.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine XTCY.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Meris Kott | xtacytherapeutics.com |
Xtacy Therapeutics Corp. formerly known as Global Wellness Strategies Inc. is an incubator, venture capital and accelerator firm specializing in incubation and startup. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet.
Xtacy Therapeutics Corp. Fundamentals Summary
| XTCY.F fundamental statistics | |
|---|---|
| Market cap | US$1.08m |
| Earnings (TTM) | -US$144.77k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-7.4x
P/E RatioIs XTCY.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XTCY.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$195.68k |
| Earnings | -CA$195.68k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0034 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -5.1% |
How did XTCY.F perform over the long term?
See historical performance and comparison